🧬 The field of regenerative medicine is expanding at an exciting pace, with many new options on the table.
🧬While regenerative medicine may sound like a buzzword, it’s far from new. Since the 1990s, it’s been used in specialties like neurology, cardiology, orthopaedics, and oncology. Cellular therapies like PRP , fat cells and stem cells have paved the way, but they also come with regulatory, ethical, logistical and cost-related challenges.
🧬Enter the new frontier: non-cellular regenerative therapies. These include growth factors, exosomes, and polynucleotide, offering the potential for tissue regeneration, repair, and rejuvenation without the complexity of live cells.
🧬Let’s break it down:
1. Growth Factors – Signalling proteins that stimulate cellular repair and fibroblast activity. These can be derived from plants or humans.
2. Exosomes – Tiny extracellular vesicles secreted by stem cells. These vesicles carry microRNA, growth factors
and lipids, stimulating cellular repair and reducing inflammation. Because microRNA is non-coding, exosomes can be sourced from plants.
3. Polynucleotides – Sourced from salmon DNA, these fragments of RNA/DNA improve microcirculation, reduce inflammation, and encourage fibroblast activity. They have antioxidant and wound-healing benefits too.
🧬But caution is key:
Not all products are created equal. GMP-certified manufacturing, peer-reviewed studies, and transparent safety data are essential. Regulation in this space is evolving—practitioners must remain vigilant and evidence-based.
🧬At AAMSSA, we believe the future of aesthetics lies in safe, ethical regenerative innovation that harnesses the body’s own capacity to heal and restore. After all, self-healing is the ultimate aesthetic goal.